123953 Results for: "(5-Methyl-1H-pyrazol-1-yl)acetic+acid&pageNo=12"

Supplier: Abcam

Alexa Fluor® 488 Rabbit monoclonal [EPR17899] to Histone H3.3.

Supplier: Abcam

Alexa Fluor® 555 Rabbit monoclonal [EPR23241-224] to L1CAM.

Supplier: Abcam

FITC Rabbit monoclonal [cFosS32-BA9] to c-Fos (phospho S32).

Supplier: Abcam

Alexa Fluor® 647 Rabbit monoclonal [EPR20844-15] to CCR2.

Supplier: Abcam

Alexa Fluor® 700 Mouse monoclonal [MEM-15] to CD14.

Supplier: Abcam

Biotin Rabbit monoclonal [BtkY551-G12] to BTK (phospho Y551).

Supplier: Abcam

FITC Rabbit monoclonal [MSK1T581-A5] to MSK1 (phospho T581).

Supplier: Abcam

Alexa Fluor® 488 Rabbit monoclonal [EPR23563-120] to HHLA2.

Supplier: Abcam

Alexa Fluor® 488 Rat monoclonal [EPR15581-39] to TOMM20 - Chimeric.

Supplier: Abcam

PE Rabbit monoclonal [Chk1S345-R3F9] to Chk1 (phospho S345).

Supplier: Abcam

PE Rabbit monoclonal [KSR1S392-3A4] to KSR1 (phospho S392).

Supplier: Abcam

Alexa Fluor® 647 Rabbit monoclonal [EPR26490-88] to CEACAM1.

Supplier: Abcam

Alexa Fluor® 647 Rabbit monoclonal [Y284] to C Reactive Protein.

Supplier: Cayman Chemical

Anti-Cytokeratin Mouse Monoclonal Antibody (FITC (Fluorescein Isothiocyanate)) [clone: C-11]

Supplier: Apollo Scientific

1-Piperidinecarboxylic acid-3-fluoro-4-[(phenylmethyl)amino]-(3S,4R)-1,1-dimethylethyl ester

Supplier: Apollo Scientific

Contains 600 mg/L calcium nitrate and 200 mg/L casein; without ammonium nitrate.

Supplier: Abcam

PE Rabbit monoclonal [BLNKY84-H4] to BLNK (phospho Y84).

Supplier: Abcam

PE Rabbit monoclonal [SEK1MKK4S257-C5] to MEK4/MKK4 (phospho S257).

Supplier: Abcam

FITC Rabbit monoclonal [PKCgT514-PF4] to PKC (phospho T514).

Supplier: Abcam

Alexa Fluor® 647 Rabbit monoclonal [EPR20266] to Cardiac Troponin T.

Supplier: Biotium

This antibody recognizes a protein of 25-26 kDa, identified as the bcl-2 α oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 α oncoprotein inhibits programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 α protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative.

Supplier: Biotium

This antibody recognizes a protein of 25-26 kDa, identified as the bcl-2 α oncoprotein. It shows no cross-reaction with Bcl-x or Bax protein. Expression of bcl-2 α oncoprotein inhibits programmed cell death (apoptosis). In most follicular lymphomas, neoplastic germinal centers express high levels of bcl-2 α protein, whereas the normal or hyperplastic germinal centers are negative. Consequently, this antibody is valuable when distinguishing between reactive and neoplastic follicular proliferation in lymph node biopsies. It may also be used in distinguishing between those follicular lymphomas that express bcl-2 protein and the small number in which the neoplastic cells are bcl-2 negative.

Supplier: Biotium

MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.

Supplier: Biotium

MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.

Supplier: Tonbo Biosciences

The MEL-14 antibody is specific for mouse CD62L, also known as L-Selectin, a cell adhesion molecule which facilitates lymphocyte "rolling" on activated vascular endothelium and homing to high endothelial venules (HEV) as immune cells transmigrate from blood into peripheral tissues. L-Selectin is a member of a family of Selectin molecules which act together with the integrin family of adhesion molecules to mediate leukocyte-endothelial interactions. L-Selectin is characteristically expressed by neutrophils, and is also found on B cells, monocytes, granulocytes, and at varying levels on naive, effector and memory T cells. It is rapidly shed upon cell activation, releasing into the circulation a soluble form whose biological role is of particular interest in cancer biology research. The MEL-14 antibody may be used as a phenotypic marker for CD62L expression on a variety of immune cell types. Please note that CD62L (L-Selectin) itself is also referred to as MEL-14 in the literature.

Supplier: Biotium

MAb IPO-10 defines the antigen, which appears on B cell progenitors following HLA-DR and preceding CD10, CD19, CD22, CD37 and cym. It is expressed on resting B cells and than reappears and persists in cytoplasm and on cell surface until cytoplasmic Ig appears. It is a useful antibody for diagnostics of neoplasms of B cell origins. It reacts with human B cell lines Daudi, Raji, Namalva, EB-3, RPMI-8226 (50% of cells). The MAb does not label T cell lines, blood granulocytes, thymocytes or bone marrow stromal fibroblasts. No significant changes are detected after PHA or ConA stimulation while LPS and PWM stimulated cultures after 18-48h show decreased number of antigen-positive cells but in final terms of cultivation antigen is expressed again. This MAb labels B cell leukemias and some lymphomas. Hairy cell leukemia strongly reacts and 70% of B cell CLL and some B-NHL were also positive. IPO-10 reacts with AMML cells and in a majority of Hodgkin's disease cases a significant percentage of affected lymph node cells were detected.

Supplier: US Biological

Anti-Interleukin-17 Receptor A Rabbit Polyclonal Antibody (HRP (Horseradish Peroxidase))

Supplier: US Biological

Anti-CDH10 Rabbit Polyclonal Antibody (HRP (Horseradish Peroxidase))

Supplier: Abcam

Rabbit monoclonal [032] to LDL Receptor - BSA and Azide free.

Supplier: Abcam

FITC Rabbit monoclonal [Chk2T68-D12] to Chk2 (phospho T68).